Carbapenem resistance in Enterobacteriaceae: here is the storm!

By P. Nordmann, L. Dortet, L. Poirel. Trends in Molecular Medicine, 2012

1,018 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Carbapenem Resistance: A Review (2017, background): “These are to improve the detection of unknown, dominant resistance genes and their variants to control sporadic dissemination into health-care facilities and community settings [117].”
Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance (2015, background): “NDM, VIM, and IMP producers remain susceptible to aztreonam, while OXA-48-like producers may test susceptible to the expandedspectrum cephalosporins in approximately 20% of the cases (14).”
Dissemination of Antimicrobial Resistance in Microbial Ecosystems through Horizontal Gene Transfer (2016, background): “With a lack of development of new antibiotics, and increasing resistance even to last-resort antibiotics (Nordmann et al., 2012), there is a need to conserve the ones available.”
Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods (2016, methodology): “New-Delhi metallo-β-lactamase-producing K. pneumoniae are usually resistant to most β-lactam antibiotics but remain susceptible to aztreonam (Nordmann et al., 2012a).”